LMAT Quote, Financials, Valuation and Earnings

Integra Lifesciences Holdings has a net margin of 18.39% compared to LeMaitre Vascular's net margin of -6.61%. LeMaitre Vascular's return on equity of 13.74% beat Integra Lifesciences Holdings's return on equity of -1.88%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 26.5%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $16.13 which suggests that it could grow by 33.27%. Given that Integra Lifesciences Holdings has higher upside potential than LeMaitre Vascular, analysts believe Integra Lifesciences Holdings is more attractive than LeMaitre Vascular.

LeMaitre Vascular has a beta of 0.816, which suggesting that the stock is 18.388% less volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.152, suggesting its more volatile than the S&P 500 by 15.175%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.87%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Integra Lifesciences Holdings quarterly revenues of $382.7M. LeMaitre Vascular's net income of $11M is higher than Integra Lifesciences Holdings's net income of -$25.3M. Notably, LeMaitre Vascular's price-to-earnings ratio is 41.72x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.34x versus 0.57x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 30.99%. LeMaitre Vascular's return on equity of 13.74% beat Intuitive Surgical's return on equity of 15.82%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 26.5%. On the other hand Intuitive Surgical has an analysts' consensus of $581.45 which suggests that it could grow by 13.42%. Given that LeMaitre Vascular has higher upside potential than Intuitive Surgical, analysts believe LeMaitre Vascular is more attractive than Intuitive Surgical.

LeMaitre Vascular has a beta of 0.816, which suggesting that the stock is 18.388% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.642, suggesting its more volatile than the S&P 500 by 64.249%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.87%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. LeMaitre Vascular's net income of $11M is lower than Intuitive Surgical's net income of $698.4M. Notably, LeMaitre Vascular's price-to-earnings ratio is 41.72x while Intuitive Surgical's PE ratio is 75.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.34x versus 21.35x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 18.39% compared to LeMaitre Vascular's net margin of -45.89%. LeMaitre Vascular's return on equity of 13.74% beat Masimo's return on equity of -39.91%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 26.5%. On the other hand Masimo has an analysts' consensus of $184.37 which suggests that it could grow by 15.63%. Given that LeMaitre Vascular has higher upside potential than Masimo, analysts believe LeMaitre Vascular is more attractive than Masimo.

LeMaitre Vascular has a beta of 0.816, which suggesting that the stock is 18.388% less volatile than S&P 500. In comparison Masimo has a beta of 1.187, suggesting its more volatile than the S&P 500 by 18.716%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.87%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Masimo quarterly revenues of $372M. LeMaitre Vascular's net income of $11M is higher than Masimo's net income of -$170.7M. Notably, LeMaitre Vascular's price-to-earnings ratio is 41.72x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.34x versus 4.38x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 13.56%. LeMaitre Vascular's return on equity of 13.74% beat Teleflex's return on equity of 3.41%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 26.5%. On the other hand Teleflex has an analysts' consensus of $151.02 which suggests that it could grow by 33.27%. Given that Teleflex has higher upside potential than LeMaitre Vascular, analysts believe Teleflex is more attractive than LeMaitre Vascular.

LeMaitre Vascular has a beta of 0.816, which suggesting that the stock is 18.388% less volatile than S&P 500. In comparison Teleflex has a beta of 1.080, suggesting its more volatile than the S&P 500 by 8.03%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.87%. Teleflex offers a yield of 1.2% to investors and pays a quarterly dividend of $0.34 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Teleflex quarterly revenues of $700.7M. LeMaitre Vascular's net income of $11M is lower than Teleflex's net income of $95M. Notably, LeMaitre Vascular's price-to-earnings ratio is 41.72x while Teleflex's PE ratio is 35.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.34x versus 1.76x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.